These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31284182)

  • 21. Prospective Associations between Single Foods, Alzheimer's Dementia and Memory Decline in the Elderly.
    Fischer K; Melo van Lent D; Wolfsgruber S; Weinhold L; Kleineidam L; Bickel H; Scherer M; Eisele M; van den Bussche H; Wiese B; König HH; Weyerer S; Pentzek M; Röhr S; Maier W; Jessen F; Schmid M; Riedel-Heller SG; Wagner M
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29966314
    [No Abstract]   [Full Text] [Related]  

  • 22. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer's Disease?
    Hegde V; Dhurandhar NV; Reddy PH
    J Alzheimers Dis; 2019; 72(s1):S71-S79. PubMed ID: 31744006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart diseases and long-term risk of dementia and Alzheimer's disease: a population-based CAIDE study.
    Rusanen M; Kivipelto M; Levälahti E; Laatikainen T; Tuomilehto J; Soininen H; Ngandu T
    J Alzheimers Dis; 2014; 42(1):183-91. PubMed ID: 24825565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.
    Mayeux R; Small SA; Tang M; Tycko B; Stern Y
    Neurobiol Aging; 2001; 22(4):683-9. PubMed ID: 11445269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How can elderly apolipoprotein E ε4 carriers remain free from dementia?
    Ferrari C; Xu WL; Wang HX; Winblad B; Sorbi S; Qiu C; Fratiglioni L
    Neurobiol Aging; 2013 Jan; 34(1):13-21. PubMed ID: 22503000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mid-life proteinuria and late-life cognitive function and dementia in elderly men: the Honolulu-Asia Aging Study.
    Higuchi M; Chen R; Abbott RD; Bell C; Launer L; Ross GW; Petrovitch H; Masaki K
    Alzheimer Dis Assoc Disord; 2015; 29(3):200-5. PubMed ID: 25626635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study.
    Tyas SL; White LR; Petrovitch H; Webster Ross G; Foley DJ; Heimovitz HK; Launer LJ
    Neurobiol Aging; 2003; 24(4):589-96. PubMed ID: 12714116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance is associated with poorer verbal fluency performance in women.
    Ekblad LL; Rinne JO; Puukka PJ; Laine HK; Ahtiluoto SE; Sulkava RO; Viitanen MH; Jula AM
    Diabetologia; 2015 Nov; 58(11):2545-53. PubMed ID: 26276262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort Study.
    Udeh-Momoh C; Price G; Ropacki MT; Ketter N; Andrews T; Arrighi HM; Brashear HR; Robb C; Bassil DT; Cohn M; Curry LK; Su B; Perera D; Giannakopoulou P; Car J; Ward HA; Perneczky R; Novak G; Middleton L
    J Prev Alzheimers Dis; 2019; 6(4):256-266. PubMed ID: 31686098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study.
    Peila R; White LR; Petrovich H; Masaki K; Ross GW; Havlik RJ; Launer LJ
    Stroke; 2001 Dec; 32(12):2882-9. PubMed ID: 11739991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Risk of Incident Alzheimer's Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline.
    Wolfsgruber S; Kleineidam L; Wagner M; Mösch E; Bickel H; Lϋhmann D; Ernst A; Wiese B; Steinmann S; König HH; Brettschneider C; Luck T; Stein J; Weyerer S; Werle J; Pentzek M; Fuchs A; Maier W; Scherer M; Riedel-Heller SG; Jessen F;
    J Alzheimers Dis; 2016 Oct; 54(3):1135-1146. PubMed ID: 27567852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
    Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.